RAPID MICRO BIOSYSTEMS, INC. - Class A common stock, $0.01 par value per share (RPID)

CUSIP: 75340L104

Q3 2023 13F Holders as of 30 Sep 2023

Holder snapshot 6 signals
Share change
-416,082
SEC-reported price per share
$1.08
Number of holders
22
Value change
-$417,040
Number of buys
5
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
45,651,578

Security key

75340L104

Report period

Q3 2023

Institutions

22

Top holders

10

Ownership snapshot

Top reported holders of RPID - RAPID MICRO BIOSYSTEMS, INC. - Class A common stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
KENNEDY LEWIS MANAGEMENT LP
Disclosed value leader
KENNEDY LEWIS MANAGEMENT LP
Comparable rows
0/15
Latest evidence
30 Jun 2023
3/4/5 13F Highest disclosed value: $13,548,284 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

KENNEDY LEWIS MANAGEMENT LP has the largest disclosed position value at $13.55M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens KENNEDY LEWIS MANAGEMENT LP's linked filing trail.
Disclosed position value Top 5
KENNEDY LEWIS MANAGEMENT LP $13.55M
Gurinder Grewal $291.9K
Longitude Prime Partners, LLC $148.4K
Bain Capital Life Sciences Invest... $8.43M
JPMORGAN CHASE & CO $1.44M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
KENNEDY LEWIS MANAGEMENT LP
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$13,548,284
2,904,490 shares
— 02 Jun 2022
Gurinder Grewal
3/4/5
10%+ Owner
—
denominator unverified
$291,863
294,990 shares
— 19 Jul 2021
Longitude Prime Partners, LLC
3/4/5
10%+ Owner
—
denominator unverified
$148,410
150,000 shares
— 19 Jul 2021
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
—
denominator unverified
$8,434,560
8,434,560 shares
— 30 Jun 2023
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$1,435,707
1,435,707 shares
— 30 Jun 2023
GLENVIEW CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$1,318,288
1,318,288 shares
— 30 Jun 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
22
Shares
21,456,755
Rows available
22
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2026 Across Filers

Q2 2026 holders
35
Q3 2023 holders
22
Holder diff
-13
Investor Q2 2026 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2026 value Q3 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .